MillenniumPost

‘Lethal’ changes

31 Oct 2023 6:20 PM IST
The proposed amendments to India’s patent laws are a capitulation to Big Pharma and will undermine vital public health safeguards in the law

Pair of perils

24 Oct 2023 5:32 PM IST
While a few generic giants, including one from Israel, are found guilty of fuelling fatal opioid crisis in the US, the US-backed “genocide” targeting...

Turning back the pages

11 April 2023 6:47 PM IST
The 2013 landmark Supreme Court judgement of 'Novartis v Union of India' offers critical lessons on the intent behind crucial aspects of India’s key...

Spurious endeavour

6 April 2023 6:39 PM IST
The move to foist a GI tag on Mandu’s baobab tree is part of a drive to push up the GI tally which does not benefit local communities

Trade lessons from 'Cuetlaxochitl'

24 Dec 2022 8:49 PM IST
The story of poinsettia, a flower with showy-red bracts used for Christmas decorations in America since the 16th century, is a classic example of...

Where do we stand?

13 Oct 2022 4:03 PM IST
Policy blocks and poor vision have held up 5G in India, while China’s breakthroughs are helping to set global standards

A lethal lapse

29 Sept 2022 9:28 PM IST
Cancer and tuberculosis patients have been urging a reluctant government to use compulsory licences to make life-saving drugs accessible

Battle for prestige

15 Sept 2022 7:45 PM IST
Moderna is trying to be gatekeeper for the mRNA platform for future drug development — raising monopolistic fears

Repeat of a failure?

25 Aug 2022 11:30 PM IST
A pattern familiar to Covid-19 is emerging in the battle against monkeypox, with the US and Europe grabbing scarce vaccine supplies

Done with vaccines?

28 July 2022 8:43 PM IST
India claims vaccines are no longer an issue in the battle against COVID-19, but a host of developing nations would disagree

A tool of war?

27 July 2022 7:24 PM IST
Post the Ukraine war, Russia has held back from appropriating intellectual property despite having a law to punish unfriendly countries

Charity after profiteering!

19 Jun 2022 12:47 AM IST
After facing a worldwide censure for earning disproportionately during the pandemic, pharma giant Pfizer has decided to supply its patented,...
Share it